Stoke Therapeutics (STOK) vs First Tracks Biotherapeutics (TRAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Stoke Therapeutics is the larger company by market cap ($1.75 billion vs $1.75 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | STOK | TRAX |
|---|---|---|
| Share price | $26.81 | $41.64 |
| Market cap | $1.75B | $1.75B |
| 1-day change | -0.45% | -6.34% |
| YTD return | -15.53% | — |
| 1-year return | -8.62% | — |
| 5-year return | +6.77% | — |
| EPS (TTM) | $-3.81 | $-4.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $184.42M | — |
| Revenue growth (YoY) | +404.50% | — |
| Net income (latest FY) | $-6.88M | — |
| Operating margin | -11.16% | — |
| Net margin | -3.73% | — |
| 52-week high | $40.22 | $54.78 |
| 52-week low | $22.05 | $14.72 |
| Distance from 52-week high | -33.34% | -23.99% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +73.00% | +80.52% |
| Average volume | 1.02M | 826.70K |
| Shares outstanding | 65.41M | 42.02M |
| Employees | 170 | 104 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Stoke Therapeutics
STOK stock →Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression.
Health Care · Biotechnology: Pharmaceutical Preparations · 170 employees
About First Tracks Biotherapeutics
TRAX stock →First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees
STOK vs TRAX FAQ
Which is bigger, Stoke Therapeutics or First Tracks Biotherapeutics?
Stoke Therapeutics (STOK) is larger, with a market capitalization of $1.75B compared with $1.75B for First Tracks Biotherapeutics (TRAX).
Are Stoke Therapeutics and First Tracks Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.